Epstein‐Barr Virus–Associated Central Nervous System Lymphoproliferative Disease in a Patient with Acquired Immunodeficiency Syndrome Responsive to Highly Active Antiretroviral Therapy
Author(s) -
Dennis Z. Kuo,
Aaron M. Milstone,
Stephanie O. Omokaro,
Alan D. Friedman,
Zarir E. Karanjawala,
Michael J. Borowitz,
Mary Joyner,
Neal A. Halsey,
Erica Ms Sibinga
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/587111
Subject(s) - medicine , antiretroviral therapy , central nervous system , lymphoproliferative disease , disease , lymphoproliferative disorders , immunodeficiency , immunology , viral disease , human immunodeficiency virus (hiv) , pathology , lymphoma , viral load , immune system
A 20-year-old man with acquired immunodeficiency syndrome (AIDS) and central nervous system (CNS) lymphoproliferative disease experienced improvement with highly active antiretroviral therapy (HAART) without radiation therapy. Our experience highlights the importance of biopsy in evaluating multifocal radiographic CNS lesions and the central role of HAART in treating AIDS-related CNS disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom